News Release

Gallo Prostate Cancer Center Welcomes New Member to Community Advisory Board

Rebecca Perkins Named to Panel at The Cancer Institute of New Jersey
March 4, 2011

New Brunswick, N.J. –Warren Township resident Rebecca Perkins, president and chief executive officer of The Perkins Partnership, has been named as a member to the Dean and Betty Gallo Prostate Cancer Center’s Community Advisory Board at The Cancer Institute of New Jersey (CINJ). The Dean and Betty Gallo Prostate Cancer Center is a specialized prostate health resource offering outreach and education activities statewide, as well as a hub for prostate cancer research. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

“Our organization is fortunate to have Rebecca as a member of its Community Advisory Board,” said Board Chair Betty Gallo, who also is the director of public outreach and government affairs for the Dean and Betty Gallo Prostate Cancer Center. “We welcome her expertise in advocacy and her participation in our continuing efforts to educate the public about prostate cancer,” she added.

Gallo noted that Perkins was selected due to her extensive experience in patient advocacy and healthcare initiatives.  Along with her leadership role at The Perkins Partnership, a public policy consulting firm focusing on healthcare advocacy, Perkins previously served as senior vice president of the HealthCare Institute of New Jersey. Other positions during her career include executive vice president and chief operating officer of Prosperity New Jersey; and special assistant to the president of the University of Medicine and Dentistry of New Jersey for external affairs.

Other members of the Community Advisory Board include: Gilbert Grant, William Major, Ildiko Peluso, Robert Peluso, David Plotkin, Edward Rochford, Alicia Saunders, Robert Schermer, Christopher Schmidt, Michael Tuosto and Philip Vinick.

Additional information on the Dean and Betty Gallo Prostate Cancer Center can be found at: www.cinj.org/treatment/prostate_cancer.html

About The Cancer Institute of New Jersey
The Cancer Institute of New Jersey (www.cinj.org) is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center dedicated to improving the detection, treatment and care of patients with cancer, and serving as an education resource for cancer prevention. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life.  To make a tax-deductible gift to support CINJ, call 732-235-8614 or visit www.cinjfoundation.org. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School. 

The CINJ Network is comprised of hospitals throughout the state and provides the highest quality cancer care and rapid dissemination of important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. System Partner: Meridian Health (Jersey Shore University Medical Center, Ocean Medical Center, Riverview Medical Center, Southern Ocean Medical Center, and Bayshore Community Hospital). Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Memorial Hospital, Carol G. Simon Cancer Center at Overlook Hospital, and Cooper University Hospital. Affiliate Hospitals: CentraState Healthcare System, JFK Medical Center, Mountainside Hospital, Raritan Bay Medical Center, Robert Wood Johnson University Hospital Hamilton (CINJ Hamilton), Somerset Medical Center, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate

 

 

 

 

Contact: 
Michele Fisher
Phone: 
732-235-9872